NCT06260943Recruiting
Targeted Navigation in Hepatocellular Carcinoma (HCC)
Targeted Navigation to Achieve Health Equity: Increasing Access to Care, Patient Engagement and Research Participation
Source: ClinicalTrials.gov · Last updated 2 Nov 2026
Brief summary (registry, in English)
The investigators are trying to learn more about the personal perceptions and experiences regarding the needs of patients with liver cancer to help improve the care of all patients. The investigators would like to know whether there are needs that patients have or are aware of, especially those needs that the investigators have not been able to address. The investigators aim to develop a program that helps participants and participant's families to navigate the process of being diagnosed with liver cancer and receiving treatment.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 210 (estimated)
- First submitted
- 7 Feb 2024
- Start date
- 15 Apr 2024
- Primary completion date
- 15 Oct 2026
- Lead sponsor
- University of Miami
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT06260943
What you commit to
- Study type: Interventional
- Planned participants: 210
- From 15 Apr 2024 to the primary completion date, 15 Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- West Haven Grade 2 or higher hepatic encephalopathy19 or other cognitive impairment.
Other
- Unable to speak Spanish or English
- Adults unable or unwilling to consent
- Individuals who are not yet adults (infants, children, teenagers)
- Prisoners
- Given that this study is minimal risk and there are no risks to a potential fetus, investigators will not exclude pregnant women; however, no data about pregnancy or their fetus is being collected
Who the study is looking for
- HCC Patients:
- Enrolled or eligible for enrollment in Unified Prospective Registry and Biorepository of Patients with Chronic Liver Disease or Hepatobiliary Cancers Including Hepatocellular Carcinoma (HCC) and Cholangiocarcinoma.
- Diagnosis of hepatocellular carcinoma, confirmed by clinical chart review and International Classification of Diseases, Tenth Revision (ICD-10) C22.0.
- Adults, age 18 or older
- Able to provide informed consent
- All other interviewees:
- Advocates who will self-identify as having had HCC.
- Others who self-identify as either a caregiver or support person of an HCC patient.
- Physicians/Licensed Independent Practitioners, Social Workers, Nurse Navigators, and Research Coordinators will all self-identify as being involved in the care of HCC patients.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Miami Coordinator of this site? Confirm its status | Miami | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.